We observed a much greater COVID-19-dependent response (concentrations IgG and IgM SARS-CoV-2) in cancer breast, lung, and colon patients, independent of oncological therapy and vaccination (Figs. 3, 4). This evidence concerns the gene CD40LG and cancer.